This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: The First Affiliated Hospital, Third Military University, Pla, Tianjin Chase Sun Pharmaceutical Co., Ltd. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Guo Wei: Innovator in Pharmaceutical Applications
Introduction
Guo Wei is a notable inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for sepsis. His innovative work has the potential to impact clinical practices significantly.
Latest Patents
Guo Wei holds a patent for "Salts of kukoamine B, preparation method and use thereof." This patent focuses on the preparation method and pharmaceutical applications of salts of kukoamine B in the prevention and treatment of sepsis. Experimental results indicate that these salts effectively antagonize key factors that induce sepsis. Given the current lack of effective treatment options for sepsis in clinical settings, his medicinal formulations offer a promising new approach.
Career Highlights
Throughout his career, Guo Wei has worked with several reputable institutions, including The First Affiliated Hospital of the Third Military University and Tianjin Chase Sun Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.
Collaborations
Guo Wei has collaborated with notable colleagues such as Jiang Zheng and Xinchuan Zheng. Their combined efforts have further advanced the research and application of his innovative pharmaceutical solutions.
Conclusion
Guo Wei's contributions to the field of pharmaceuticals, particularly in the treatment of sepsis, highlight his role as an influential inventor. His work not only addresses a critical medical need but also paves the way for future innovations in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile